BACKGROUND: Although the effectiveness of Lp(a) (lipoprotein[a])–lowering therapies remains under study, lipid guidelines now recommend Lp(a) testing in all adults to identify individuals who need ...
The fully electric vehicle offers testing for STI’s and connection to care for people who test positive for HIV. The mobile unit will also offer anytime access to pre-exposure prophylaxis or PrEP via ...
Horizon Health’s Paris Clinic will host a discounted health screening event on September 11, offering three screenings for ...
District Health Department #10, along with other regional healthcare partners, will be hosting a health fair and mobile ...
LAKE COUNTY, Calif. — Due to an unanticipated building maintenance need, OptumServe has made the difficult decision to close their Lakeport COVID-19 testing and vaccination site. This closure was ...
A rapid microbiological point-of-care test designed to help GPs identify whether a respiratory infection is caused by a virus did not lead to an expected overall reduction in same-day antibiotic ...
Offering universal human papillomavirus (HPV) self-testing in primary care was both non-inferior and superior to clinician-sampled Pap smear. Underscreened and marginalized groups saw the most benefit ...
Nourish, a virtual nutrition provider, is launching a program that gives patients access to free cardiometabolic lab testing. Nourish Labs will integrate blood testing into personalized nutrition care ...
NEW YORK--(BUSINESS WIRE)--Nourish, the leading metabolic health provider powered by the largest dietitian network in the country, today announced the launch of Nourish Labs, a new program that gives ...
Integrating a rapid point-of-care polymerase chain reaction (PCR) testing for sexually transmitted infections (STIs) in the emergency department (ED) reduced the length of stay of patients by 76 ...
The projected fair value for Leong Hup International Berhad is RM1.00 based on 2 Stage Free Cash Flow to Equity Current share price of RM0.77 suggests Leong Hup International Berhad is potentially 23% ...
Following the successful completion of the NHS national pilot in April 2025, the highly anticipated first results assessing CYP2C19 genetic testing to guide clopidogrel use in ischaemic stroke and TIA ...